Next Article in Journal
Soft Coral Dendronephthya puetteri Extract Ameliorates Inflammations by Suppressing Inflammatory Mediators and Oxidative Stress in LPS-Stimulated Zebrafish
Next Article in Special Issue
Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of F9 into rDNA Locus of Mouse ESCs
Previous Article in Journal
The “Frail” Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections
Previous Article in Special Issue
Recent Progress in Gene Therapy for Ovarian Cancer
Open AccessArticle

Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer

Department of Anatomy, Chonnam National University Medical School, Gwangju 61469, Korea
Institute of Genome Research, Vietnam Academy of Science and Technology, Hanoi 122121, Viet Nam
Department of Urology, Chonnam National University Medical School, Gwangju 61469, Korea
Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Korea
Department of Hemato-Oncology, Chonnam National University Medical School, Gwangju 61469, Korea
Genitourinary Cancer Branch, Research Institute of National Cancer Center, Goyang 10408, Gyeonggi-do, Korea
Institute of Molecular Life Sciences, University of Zurich, Zurich 8057, Switzerland
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(9), 2694;
Received: 20 August 2018 / Revised: 30 August 2018 / Accepted: 6 September 2018 / Published: 10 September 2018
(This article belongs to the Special Issue Gene Therapy)
PDF [4035 KB, uploaded 10 September 2018]


CD46 is generally overexpressed in many human cancers, representing a prime target for CD46-binding adenoviruses (Ads). This could help to overcome low anti-tumoral activity by coxsackie-adenoviral receptor (CAR)-targeting cancer gene therapy viruses. However, because of scarce side-by-side information about CAR and CD46 expression levels in cancer cells, mixed observations of cancer therapeutic efficacy have been observed. This study evaluated Ad-mediated therapeutic efficacy using either CAR-targeting Ad5 or CD46-targeting Ad5/35 fiber chimera in bladder cancer cell lines. Compared with normal urothelia, bladder cancer tissue generally overexpressed both CAR and CD46. While CAR expression was not correlated with disease progression, CD46 expression was inversely correlated with tumor grade, stage, and risk grade. In bladder cancer cell lines, expression levels of CD46 and CAR were highly correlated with Ad5/35- and Ad5-mediated gene transduction and cytotoxicity, respectively. In a human EJ bladder cancer xenograft mouse model, with either overexpressed or suppressed CD46 expression levels, Ad5/35-tk followed by ganciclovir (GCV) treatment significantly affected tumor growth, whereas Ad5-tk/GCV had only minimal effects. Overall, our findings suggest that bladder cancer cells overexpress both CAR and CD46, and that adenoviral cancer gene therapy targeting CD46 represents a more suitable therapy option than a CAR-targeting therapy, especially in patients with low risk bladder cancers. View Full-Text
Keywords: CD46; CAR; adenovirus; gene therapy; bladder cancer CD46; CAR; adenovirus; gene therapy; bladder cancer

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Do, M.-H.; To, P.K.; Cho, Y.-S.; Kwon, S.-Y.; Hwang, E.C.; Choi, C.; Cho, S.-H.; Lee, S.-J.; Hemmi, S.; Jung, C. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer. Int. J. Mol. Sci. 2018, 19, 2694.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top